DEUTSCHE BANK AG\ - PREVAIL THERAPEUTICS INC ownership

PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$248,000
+210.0%
10,768
+36.6%
0.00%
Q3 2020$80,000
-25.2%
7,882
+9.6%
0.00%
Q2 2020$107,000
+75.4%
7,194
+42.7%
0.00%
Q1 2020$61,000
+52.5%
5,043
+95.8%
0.00%
Q4 2019$40,000
+60.0%
2,575
+25.1%
0.00%
Q3 2019$25,0002,0590.00%
Other shareholders

There were no reported owners of PREVAIL THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of PREVAIL THERAPEUTICS INC shareholders